© 2002 European Society of Cardiology
Thyronin treatment in adult and pediatric heart surgery: clinical experience and review of the literature
a Department of Cardiovascular Surgery, University Hospital CH-3010 Berne, Switzerland
b Division of Cardiology, University Hospital CH-3010 Berne, Switzerland
* Corresponding author. Tel.: +41-31-632-2375; fax: +41-31-632-4443. E-mail address: thierry.carrel{at}insel.ch
 |
Abstract |
|---|
Thyroid hormone has multiple direct and indirect effects on the heart and the vasculature. Many signs and symptoms of thyroid dysfunction are manifest by the cardiovascular system. Furthermore, many cardiovascular diseases are adversely affected by the concomitant presence of either hyper- or hypothyroidism: it is still being debated whether these alterations are the consequence of increased cardiac workload alone or are due to the intrinsic properties of thyroid hormone. There are three potential mechanisms by which thyroid hormone might exert a cardiovascular action: (1) direct effects at the cellular level (inotropic and chronotropic effect); (2) interaction with the sympathetic nervous system; and (3) alteration of the peripheral circulation through changes in preload, afterload and energy metabolism. We treated 54 adult and seven pediatric patients suffering from severe low cardiac output in different clinical conditions with a mean bolus dosage of 2±1.5 µg h–1 of T3, followed by a continuous infusion of 0.4±0.3 µg h–1 for a mean duration of 48±12 h. In 45 patients, stabilization of the hemodynamic situation with a decrease in inotropic support requirement was observed; however, in 11 patients no beneficial effects were observed. From this experience we suggest that T3 treatment may improve hemodynamics in a substantial proportion of cardiac and cardiosurgical patients in whom more conventional treatment is unsuccessful.
Key Words: Thyronin • Heart surgery • Hemodynamics • Transplantation
Received May 22, 2001; Revised September 7, 2001; Accepted December 14, 2001
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  E. M. Kaptein, E. Beale, and L. S. Chan Thyroid Hormone Therapy for Obesity and Nonthyroidal Illnesses: A Systematic Review J. Clin. Endocrinol. Metab., October 1, 2009; 94(10): 3663 - 3675. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Ronald and J. Dunning Does perioperative thyroxine have a role during adult cardiac surgery? Interactive CardioVascular and Thoracic Surgery, April 1, 2006; 5(2): 166 - 178. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Kozdag, D. Ural, A. Vural, A. Agacdiken, G. Kahraman, T. Sahin, E. Ural, and B. Komsuoglu Relation between free triiodothyronine/free thyroxine ratio, echocardiographic parameters and mortality in dilated cardiomyopathy Eur J Heart Fail, January 1, 2005; 7(1): 113 - 118. [Abstract] [Full Text] [PDF]
|
|